Homozygous familial hypercholesterolemia in Lebanon: A genotype/phenotype correlation

Molecular Genetics and Metabolism

Volumn 102, Issue 2, 2011, Pages 181-188

  Fahed, Akl C ^a   Safa, Raya M ^a   Haddad, Fadi F ^a   Bitar, Fadi F ^a   Andary, Rabih R ^a   Arabi, Mariam T ^a   Azar, Sami T ^a   Nemer, Georges ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Genotype; Heart; Hypercholesterolemia; LDLR; Mutation

Indexed keywords

DNA; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CHRISTIAN; CONTROLLED STUDY; DNA SEQUENCE; EARLY DIAGNOSIS; ETHNIC DIFFERENCE; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; HEART; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; LEBANON; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PEDIGREE ANALYSIS; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; CHOLESTEROL, LDL; FEMALE; GENETIC ASSOCIATION STUDIES; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LEBANON; MALE; MIDDLE AGED; MOLECULAR TYPING; MUTATION; PEDIGREE; RECEPTORS, LDL; YOUNG ADULT;

EID: 78651439222     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2010.11.006     Document Type: Article

References (31)

1. Soutar A.K., Naoumova R.P. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nature Clinical Practice. Cardiovascular Medicine 2007, 4:214-225.
2. Khachadurian A.K. The inheritance of essential familial hypercholesterolemia. The American Journal of Medicine 1964, 37:402-407.
3. Hegele R.A. Genetic susceptibility to heart disease in Canada: lessons from patients with familial hypercholesterolemia. Genome/National Research Council Canada = Génome/Conseil national de recherches Canada 2006, 49:1343-1350.
4. Lehrman M.A., Schneider W.J., Brown M.S., et al. The Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum. The Journal of Biological Chemistry 1987, 262:401-410.
5. Steyn K., Weight M.J., Dando B.R., Christopher K.J., Rossouw J.E. The use of low density lipoprotein receptor activity of lymphocytes to determine the prevalence of familial hypercholesterolaemia in a rural South African community. Journal of Medical Genetics 1989, 26:32-36.
6. Hobbs H., Brown M., Russell D., Davignon J., Goldstein J. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. The New England Journal of Medicine 1987, 317:734-737.
7. Khachadurian A.K., Uthman S.M. Experiences with the homozygous cases of familial hypercholesterolemia. A report of 52 patients. Nutrition and Metabolism 1973, 15:132-140.
8. Yamamoto T., Davis C.G., Brown M.S., et al. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 1984, 39:27-38.
9. Südhof T.C., Goldstein J.L., Brown M.S., Russell D.W. The LDL receptor gene: a mosaic of exons shared with different proteins. Science 1985, 228:815-822.
10. Lehrman M.A., Goldstein J.L., Brown M.S., Russell D.W., Schneider W.J. Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. Cell 1985, 41:735-743.
11. Lehrman M.A., Schneide W., Südhof T.C., et al. Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains. Science 1985, 227:140-146.
12. Leigh S.E., Foster A.H., Whittall R.A., Hubbart C.S., Humphries S.E. Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Annals of Human Genetics 2008, 72:485-498.
13. University College London Low Density Lipoprotein Familial Hypercholesterolemia Database (). http://www.ucl.ac.uk/ldlr.
14. Oppenheim A., Friedlander Y., Dann E.J., et al. Hypercholesterolemia in five Israeli Christian-Arab kindreds is caused by the "Lebanese" allele at the low density lipoprotein receptor gene locus and by an additional independent major factor. Human Genetics 1991, 88:75-84.
15. Figueiredo M.S., Dos Santos J.E., Alberto F.L., Zago M.A. High frequency of the Lebanese allele of the LDLr gene among Brazilian patients with familial hypercholesterolaemia. Journal of Medical Genetics 1992, 29:813-815.
16. Alberto F.L., Figueiredo M.S., Zago M.A., Araújo A.G., Dos-Santos J.E. The Lebanese mutation as an important cause of familial hypercholesterolemia in Brazil. Brazilian Journal of Medical and Biological Research 1999, 32:739-745.
17. Day I., Whittall R., O'Dell S., et al. Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. Human Mutation 1997, 10:116-127.
18. Bodamer O.A., Bercovich D., Schlabach M., et al. Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia. Clinical Chemistry 2002, 48:1913-1918.
19. Abifadel M., Rabès J., Jambart S., et al. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene. Human Mutation 2009, 30:E682-E691.
20. Innerarity T.L., Weisgraber K.H., Arnold K.S., et al. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:6919-6923.
21. Vega G.L., Grundy S.M. In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia. The Journal of Clinical Investigation 1986, 78:1410-1414.
22. Abifadel M., Varret M., Rabès J., et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nature Genetics 2003, 34:154-156.
23. Garcia C.K., Wilund K., Arca M., et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 2001, 292:1394-1398.
24. Nicholls P., Young I.S., Graham C.A. Genotype/phenotype correlations in familial hypercholesterolaemia. Current Opinion in Lipidology 1998, 9:313-317.
25. Barbour B., Salameh P. Consanguinity in Lebanon: prevalence, distribution and determinants. Journal of Biosocial Science 2009, 41:505-517.
26. Marais A.D., Firth J.C., Blom D.J. Homozygous familial hypercholesterolemia and its management. Seminars in Vascular Medicine 2004, 4:43-50.
27. Oosterveer D.M., Versmissen J., Yazdanpanah M., Hamza T.H., Sijbrands E.J. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis. Atherosclerosis 2009, 207:311-317.
28. Sabbagh A.S., Daher R.T., Otrock Z.K., et al. ApoB-100 R3500Q mutation in the Lebanese population: prevalence and historical review of the literature. Molecular Biology Reports 2007, 34:267-270.
29. Huijgen R., Kindt I., Fouchier S.W., et al. Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemia. Human Mutation 2010, 31:752-760.
30. Morelli F., Carlier P., Giannini G., et al. Hypercholesterolemia and LDL apheresis. The International Journal of Artificial Organs 2005, 28:1025-1031.
31. Mozas P., Castillo S., Tejedor D., et al. Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR. Human Mutation 2004, 24:187.